- Membership & Community
-
Publications & News
- Journals
-
Newsroom
-
The Physiologist Magazine
- 2019
- 2020
- 2021
- 2022
- 2023
-
Mentoring Forum
- Net Worth
- Take Care
- You … In Charge
- Work. It. Out.
- Working Off-site
- Location, Location, Location?
- Student Support
- Progressing to Postdoc
- Relationship Building
- Let’s Get It Started
- What Do We Value?
- It’s a Postdoc Life
- Coronavirus Contributions
- Creative Communications
- Selection Process
- Conference Connections
- Postdoc Appreciation
- Research Rewards
- Focus on Teaching
- Industry Insights
- Balance Beam
- Post Postdoc
- If You Build It
- Mentoring Q&A
- The Physiologist Magazine Readers Survey
- Evolution
- Baseline by Scott Steen, CAE, FASAE
- Find Us on Social Media
-
The Physiologist Magazine
-
Professional Development
-
Meetings & Events
-
American Physiology Summit
- Abstracts
- Awards at the Summit
- Building APS 2023
- Distinguished Lecturers
- Game Changers
- Hotel Information
- Important Dates and Deadlines
- Industry Partners
- Industry Workshop Information
- Keynote Speaker—David Julius, PhD
- Keynote Speaker—Terrie Williams, PhD
- Meet the Organizers
- Mobile App
- Physical Poster Information
- PhysioHub
- Press Registration
- Pre-Summit Center for Physiology Education Workshop
- Pre-Summit Center for Physiology Education Workshop Registration
- Pre-Summit Events
- Registration
- Schedule at a Glance
- American Physiology Summit Program
- Section & Groups Banquet Tickets
- Shaping the Summit
- Speaker Audiovisual Instructions
- Summit FAQs
- Summit Industry Partners
- Summit Newsroom
- Summit Store
- Team 2023 Task Force
- Travel & Transportation
- Liability Waiver
- Shocklogic Test
- NIH Program Officer Panel Discussion Form
- Undergraduate Program Book
- Career Networking Lunch Form
- Scientific Integrity Policy
- Webinars
- Related Meetings
- Future APS Conferences
-
Past APS Conferences
- APS Institute on Teaching and Learning
- Integrative Physiology of Exercise
- Seventeenth International Conference on Endothelin (ET-17)
- New Trends in Sex and Gender Medicine
- APS Institute on Teaching and Learning (2022)
- Control of Renal Function in Health and Disease Conference
- Comparative Physiology: From Organisms to Omics in an Uncertain World
- Experimental Biology
- Conference Policies
-
American Physiology Summit
- Awards
-
Career & Professional Development
-
Career Gateway
-
Resources
- Transcript—Leading Through Conflict and Difficult Conversations
- Transcript—Managing Conflict with Colleagues
- Transcript—Leading a Team Through Conflict
- Transcript—Providing Difficult Feedback
- Transcript—Team Dynamics and Culture Primer
- Transcript—Building a Team
- Transcript—Leading a Team Assigned to You
- Transcript—Creating a Team Culture
-
Resources
- Career Navigator
- Center for Physiology Education
- Job Board
- Professional Skills Training Courses
- Medical Physiology Refreshers
- Mentoring
- APS Graduate Physiology & Biomedical Science Catalog
-
Career Gateway
-
Meetings & Events
-
Advocacy & Resources
- Policy Areas
-
Resources
- Researcher Resources
- Educator Resources
- Trainee Resources
- Student Resources
-
APS Graduate Physiology & Biomedical Science Catalog
- Augusta University
- Brandeis University
- Chatham University
- Des Moines University
- East Tennessee State University
- George Washington University
- Kansas State University
- Kansas State University College of Veterinary Medicine
- Louisiana State University Health Sciences Center Shreveport
- Marquette University
- Mayo Clinic Graduate School of Biomedical Sciences—Biomedical Engineering & Physiology
- Medical College of Wisconsin
- Michigan State University
- New York Medical College
- Nova Southeastern University
- Pennsylvania State University
- Rutgers Graduate Program in Physiology and Integrative Biology
- Saint Louis University
- Southern Illinois University
- Texas A&M University
- Texas A&M University Medical Physiology
- Stony Brook University
- The University of Arizona
- The University of Iowa
- The University of Mississippi Medical Center
- The University of Tennessee Health Science Center (UTHSC)
- The University of Texas at Arlington
- University of Alabama at Birmingham
- University at Buffalo
- University of California, Davis
- University of Colorado
- University of Delaware
- University of Florida
- University of Georgia College of Veterinary Medicine
- University of Louisville
- University of Michigan
- University of Minnesota
- University of Missouri-Biomedical Sciences
- University of Nebraska Medical Center
- University of New Mexico
- University of Oregon
- University of South Carolina School of Medicine
- University of Texas Health Science Center
- Wayne State University
- Wake Forest University
- Physiology Department Catalog Submission Form
- Career Gateway
- Diversity, Equity & Inclusion
- Advocacy
- About APS
Study highlights a recent example of drug repurposing
Rockville, Md. (February 15, 2023)—The drug lasmiditan, which is used to treat migraines, shows promise as a possible treatment for acute kidney injury, according to a new study from the University of Arizona. The findings are published ahead of print in the American Journal of Physiology-Renal Physiology, and the study has been chosen as an APSselect article for February.
“If it works in humans, it will be the first drug to cure acute kidney injury.” —Rick Schnellmann, PhD
Researchers conducting this study are working to develop a drug to treat acute kidney injury. The disease, which is characterized by rapid kidney failure, occurs in approximately 8 to 16% of hospitalized people and affects more than 13 million people worldwide. The condition can be caused by a variety of factors, including some medications and sepsis. Acute kidney injury can lead to physiological problems, such as mitochondrial dysfunction, damage to small blood vessels in the kidney and loss of renal tubular function. Currently, there is no treatment for acute kidney injury.
Physiologists treated a mouse model of acute kidney injury with lasmiditan and found it stimulated recovery of kidney function such as mitochondrial biogenesis (the cellular process that produces new mitochondria based on environmental and physiological changes), improved vascular integrity, reduced fibrosis and reduced proximal tubule damage. The mice were first assigned to four groups and dosed for five consecutive days, starting at 24 hours after kidney injury.
Lasmiditan is already approved by the U.S. Food and Drug Administration for treatment of migraines. Rick Schnellmann, PhD, lead author of the study and dean of the College of Pharmacy at the University of Arizona, said this is a classic example of drug repurposing. More research is needed, but Schnellmann believes these early results show promising signs of a treatment for acute kidney injury.
Read the full article, “Lasmiditan promotes recovery from acute kidney injury through induction of mitochondrial biogenesis.” It is highlighted as one of this month’s “best of the best” as part of the American Physiological Society’s APSselect program. Read all of this month’s selected research articles.
NOTE TO JOURNALISTS: To schedule an interview with a member of the research team, please contact APS Media Relations or call 301.634.7314. Find more research highlights in our Newsroom.
Physiology is a broad area of scientific inquiry that focuses on how molecules, cells, tissues and organs function in health and disease. The American Physiological Society connects a global, multidisciplinary community of more than 10,000 biomedical scientists and educators as part of its mission to advance scientific discovery, understand life and improve health. The Society drives collaboration and spotlights scientific discoveries through its 16 scholarly journals and programming that support researchers and educators in their work.
Related Content
- Exercise + Sauna = Better Cardiovascular Function
- Slower Heart Rate Protects against Heart Enlargement, Limits Exercise Capacity
- A Prune—Or Six—a Day May Keep Inflammation at Bay
- Exercise Improves Health Markers in Young Female Survivors of Childhood Trauma
- Personalized Exercise Program Improves Long COVID Symptoms
- High Caffeine Consumption Disrupts Heart Rhythms in Middle-aged Rats
- Exercise Doesn’t Change COVID-19 Booster Immune Response in People with Autoimmune Disease
Contact Us
Communications Department
844.526.1700